Salarius Pharmaceuticals Accounts Payable

Salarius Pharmaceuticals (SLRX) currently reports a accounts payable of $940K as of March 2026. That compares with $1.5M in the prior-year period — down 36.4% year over year. Use the charts on this page to explore Salarius Pharmaceuticals's accounts payable history and peer comparisons.

Salarius Pharmaceuticals's accounts payable decreased from $1.5M to $940K — a 36.4% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Salarius Pharmaceuticals reported $940K in accounts payable as of March 2026. That compares with $1.5M in the prior-year period — down 36.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $940K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Salarius Pharmaceuticals, and consider following SLRX for alerts when major investors trade the stock.

Salarius Pharmaceuticals is classified in the Healthcare sector. On accounts payable, it currently shows $940K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SLRX with unrelated industries.